AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($182.28 B vs $150.83 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMGN | GILD |
|---|---|---|
| Market cap | $182.28 B | $150.83 B |
| US-listed rank | #80 | #99 |
| Revenue (latest FY) | $36.75B | $29.44B |
| Net income (latest FY) | $7.71B | $8.51B |
| Net margin | 21.0% | 28.9% |
| P/E (trailing FY) | 23.6 | 17.7 |
| SEC filings | 1,011 | 981 |
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($182.28 B vs $150.83 B).
In their latest fiscal years, AMGEN INC reported $36.75B in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: AMGEN INC and GILEAD SCIENCES, INC., or browse the full rankings.